-
Wednesday, 01/10/2024
SEPAR AWARDS 2023 Leticia Bueno
The Spanish Society of Pulmonology and Thoracic Surgery awarded our research nurse with the "beca becario" and the first SEPAR-CHIESI 2023 award for the best communication in the nursing area.
-
Friday, 12/15/2023
Dr Miquel Ferrer Awarded Grant for Pioneering Precision Medicine Project
Dr. Miquel Ferrer has been honored with the esteemed Knowledge Generation Projects grant for his groundbreaking research project, "Interaction between risk factors, complications, sequelae, and biological basis in acute respiratory failure: towards precision medicine" (PIRAMYD). This innovative initiative, aimed at revolutionizing the treatment and management of acute respiratory failure through personalized medicine, has received recognition from the Spanish Agency of Research for its rigor and potential impact.
The PIRAMYD project, developed in collaboration with Dr. José Ángel Lorente and the team at Getafe University Hospital, focuses on deciphering the intricate relationships between genetic and environmental risk factors and their effects on patients' outcomes following acute respiratory failure. Through advanced omics data analysis, the project endeavours to pinpoint biomarkers that will facilitate tailored medical interventions for each patient, marking a significant advancement in personalized healthcare.
This grant not only provides vital financial support for the ambitious research but also underscores the significance and ingenuity of the PIRAMYD project within the medical community. Dr. Ferrer's dedication to advancing precision medicine promises to yield transformative outcomes for patient care and underscores Spain's leadership in cutting-edge medical research.
-
Friday, 10/20/2023
Denise Battaglini read her doctoral thesis
Denise Battaglini read her doctoral thesis
Denise Battaglini, an italian fellow, read her doctoral thesis on October, 20th , 2023 at the Faculty of Medicine of the University of Barcelona. Her thesis entitled: Epidemiology, risk factors and new therapeutic strategies for ventilatorassociated pneumonia: preclinical and clinical perspectives has obtained the Cum Laude qualification.
Congratulations Denise!
-
Friday, 06/30/2023
ISICIP 2023 E-POSTERS SUBMISSIONS
27th International Symposium on Infections in the Critically ill patient to be held on October 5-6 in Barcelona. ISICIP 2023
The deadline to submit your e-Poster is September 15th,2023
-
Friday, 04/28/2023
The viral load of COVID-19 at admission to the ICU determines the prognosis of patients
Madrid, April 26, 2023. New research reveals the importance of 'viral storm' in critical patients with COVID-19. The work is published in the journal The Lancet Microbe and has been carried out by several groups in the area of Respiratory Diseases (CIBERES) and the area of Infectious Diseases (CIBERINFEC) of the Biomedical Research Center in Network (CIBER)consortium attached to the Carlos III Health Institute (ISCIII). The results show that viral load in blood at admission to the ICU is a determining factor in the prognosis of critical patients with COVID-19.
-
Thursday, 04/20/2023
33rd European Congress of Clinical Microbiology and Infectious Diseases
33rd European Congress of Clinical Microbiology and Infectious Diseases in Copenhagen, Denmark April 15-18, 2023
Our researchers have participated in the Congress with oral sessions, presentations and many posters you can see following:
-
Wednesday, 04/05/2023
Specific clinical guidelines published for severe community-acquired pneumonia
Researchers from the Hospital Clínic-IDIBAPS have co-led a document on the management of severe community-acquired pneumonia, published simultaneously in the European Respiratory Journal and Intensive Care Medicine.
These are clinical guidelines that provide recommendations to standardize the treatment and management of the most critical patients.
-
Monday, 03/27/2023
Inhaled amikacin for pneumonia treatment and dissemination prevention: an experimental model of severe monolateral Pseudomonas aeruginosa pneumonia
On February 14th, 2023, an article was published in the journal Critical Care titled "Inhaled amikacin for pneumonia treatment and dissemination prevention: an experimental model of severe monolateral Pseudomonas aeruginosa pneumonia". This study, conducted by an international team of researchers led by Dr. Antoni Torres, focuses on the treatment of pneumonia caused by Pseudmonas aeruginosa.
-
Friday, 01/20/2023
Researchers from IAMR group publish in Nature Biotechnology a ‘Living medicine’ created to tackle drug-resistant lung infections.
This excellent result comes from a collaborative consortium in which our IDIBAPS-Ciberes group added an important translational value on this new promising technology developed by CRG, also with the collaboration of Institute of Agrobiotechnology (IdAB), a joint research institute of Spain’s CSIC and the government of Navarre. https://www.nature.com/articles/s41587-022-01584-9#citeas.
Researchers have designed the first ‘living medicine’ to treat lung infections. The treatment targets Pseudomonas aeruginosa, a type of bacteria which is naturally resistant to many types of antibiotics and is a common source of infections in hospitals.
The treatment involves using a modified version of the bacterium Mycoplasma pneumoniae, removing its ability to cause disease and repurposing it to attack P. aeruginosa instead. The modified bacterium is used in combination with low doses of antibiotics that would otherwise not work on their own.
Researchers tested the efficacy of the treatment in mice, finding that it significantly reduced lung infections. The ‘living medicine’ doubled mouse survival rate compared to not using any treatment. Administering a single, high dose of the treatment showed no signs of toxicity in the lungs. Once the treatment had finished its course, the innate immune system cleared the modified bacteria in a period of four days.
-
Wednesday, 01/18/2023
Anna Motos Galera read her doctoral thesis
Anna Motos Galera read her doctoral thesis
Anna Motos read her doctoral thesis on December 21st 2022 at the Faculty of Medicine of the University of Barcelona. Her thesis entitled: Novel antimicrobial agents and therapeutic approaches for nosocomial pneumonia caused by Pseudomonas aeruginosa has obtained the Cum Laude qualification.
Congratulations Anna!
